DAC 3D Dividend Growth ETF (DVGR)
Live price chart, market sentiment, and community perspectives for DAC 3D Dividend Growth ETF (NASDAQ: DVGR).
Live price chart, market sentiment, and community perspectives for DAC 3D Dividend Growth ETF (NASDAQ: DVGR).
On our desk, we are looking closely at DVGR's market positioning relative to institutional liquidity realities. With total assets sitting right around $17.5 million and a daily volume hovering around a thousand shares, execution risk is front and center. While the underlying active strategy—screening for companies that have grown dividends by at least 10% annually for over a decade—sounds bulletproof on paper, the 0.65% expense ratio feels quite steep compared to massive passive heavyweights like VIG or DGRO. If you're building a core large-value allocation, the structural friction of a micro-cap ETF wrapper is a hard sell until they scale.
From a quantitative risk perspective, DVGR presents a fascinating contradiction. Morningstar pegs its category risk as 'Low' with a beta of 0.75, but the portfolio risk score sits at 72 (Aggressive), and the trailing Sharpe and Sortino ratios are strictly negative. AGARCH volatility modeling highlights an asymmetry where negative market shocks spike near-term volatility more aggressively (with a leverage parameter gamma of 0.22). Essentially, investors have experienced a classic 'trading return for safety' scenario over its early-stage history since its December 2025 inception, without enjoying commensurate upside capture.
When evaluating DVGR for a quality-factor mandate, our clinical protocol demands looking past the marketing narrative of the '3D' screen. Yes, filtering exclusively for businesses with double-digit dividend growth over a ten-year stretch successfully weeds out yield traps and isolates premier fundamentals—evidenced by a strong 36.24% ROE and 11.74% ROA. However, analysts must grill portfolio managers on portfolio concentration risks, given the tightly packed 36-stock basket, and whether the active management alpha can sustainably overcome the drag from its 0.65% fee.
Explore plasma cleansing, somatic organ swaps, and BCI.